Delivery Order SPE2DB24D2217-SPE2DB25FJXTK
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Junel FE 1.5 mg–30 mcg tablets in quantities of 28, valued at $7,365.86. This is a firm fixed-price delivery order with no set-aside designation, executed through open competition. The work is to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 11, 2025. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Junel FE 1 mg-20 mcg tablets (28-count) at a firm fixed price ceiling value of $3,808.80. This is a non-set-aside, competitively awarded contract with an ultimate completion date of September 12, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- AmerisourceBergen Drug Corp was awarded a delivery order on August 13, 2025, by the Defense Logistics Agency for the supply of Junel Fe 1 mg-20 mcg tablets in a 28-count package. This firm fixed-price delivery order, valued at $6,653.00, is scheduled for completion by August 14, 2025, and will be fulfilled from the contractor's Conshohocken, Pennsylvania facility. The award was made through open competition with no set-aside designation and is issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,623.20 to AmerisourceBergen Drug Corp for the supply of Junel FE 1 mg-20 mcg tablets (28-count packages). This non-set-aside, competitively awarded contract utilizes firm fixed price pricing and has an ultimate completion date of August 25, 2025. The delivery order was issued on August 22, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $2,587.38 to AmerisourceBergen Drug Corp for the supply of Junel FE 1 mg-20 mcg tablets (28-count packages) on August 11, 2025. This firm fixed-price, non-set-aside contract is scheduled for completion by August 12, 2025, with performance at the vendor's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's broader relationship with the federal government for...
- The Defense Logistics Agency awarded a $1,071.66 delivery order to AmerisourceBergen Drug Corp for Junel FE 1 mg-20 mcg tablets (28-count) on July 18, 2025, with completion scheduled for July 21, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's broader contract vehicle with DLA....
- The Defense Logistics Agency awarded a delivery order valued at $3,427.92 to AmerisourceBergen Drug Corp for Junel FE 1 mg-20 mcg tablets (28-count package) on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement. The product will be performed at the contractor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $5,800.03 to AmerisourceBergen Drug Corp for the supply of Junel FE 1 mg-20 mcg tablets (28-count packages) on September 8, 2025, with completion expected by September 9, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and is classified as a child contract under a larger vehicle. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $2,285.28 to AmerisourceBergen Drug Corp on August 15, 2025, for Junel FE 1mg-20 168s pharmaceutical product. This is a firm fixed price, non-competitive delivery order under a larger indefinite delivery contract vehicle. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 18, 2025. AmerisourceBergen Drug...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,117.00 firm fixed-price contract is for the supply of Junel FE 1 mg-20 mcg tablets, a pharmaceutical product. The contract has an ultimate completion date of April 20, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves...
- SPE2DB24D2217Indefinite Delivery Contract
- SPE2DB24D2217-SPE2DB25FJXTKDelivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 11, 2025, for the supply of Junel FE 1 mg-20 mcg tablets (28-count packages) under a firm fixed-price contract. The award, valued at $1,388.16, represents a competitively awarded non-set-aside delivery order with an ultimate completion date of September 12, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The delivery order supports the DLA Medical Supply Chain's mission to provision pharmaceutical products and medical supplies for military and federal healthcare systems. AmerisourceBergen's extensive portfolio demonstrates its capability to fulfill diverse pharmaceutical requirements across multiple therapeutic domains, ranging from specialty medications to generic drugs and vaccines. As a major pharmaceutical distributor serving defense and civilian federal procurement needs, the company maintains significant capacity to execute federal medical supply contracts through its established relationships with the Defense Health Agency and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 9/11/25 |